Tehran University of Medical Sciences

Science Communicator Platform

Share By
In Vitro Combination of Antifungal Drugs With Tacrolimus (Fk506) Holds Promise Against Clinical Candida Species, Including Candida Auris Publisher Pubmed



Khodavaisy S1, 2 ; Gharehbolagh SA1 ; Abdorahimi M3 ; Rezaie S4 ; Ahmadikia K1 ; Badali H5 ; Meis JF6, 7 ; Mahmoudi S8
Authors

Source: Medical Mycology Published:2023


Abstract

In vitro interactions between tacrolimus, a calcineurin inhibitor, and fluconazole, itraconazole, caspofungin, or anidulafungin were evaluated against Candida auris, C. albicans, C. parapsilosis, and C. glabrata (each five strains). Tacrolimus-itraconazole, tacrolimus-caspofungin, and tacrolimus-fluconazole combinations resulted in synergistic interactions against 95%, 90%, and 60% of Candida isolates, respectively. However, tacrolimus-anidulafungin resulted in only a 35% synergistic effect. A combination of tacrolimus and itraconazole was most potent with synergy against 100% of C. auris, C. parapsilosis, and C. glabrata isolates. Of note, no antagonistic interaction was found. © 2023 The Author(s). Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.
Other Related Docs